This inventor holds 1 USPTO granted patent. Top assignee: Pierre Fabre Medicament. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ken Kobayashi: Innovator in Cancer Treatment
Introduction
Ken Kobayashi is a notable inventor based in San Diego, California. He has made significant contributions to the field of oncology through his innovative research and development efforts. His work focuses on the treatment of cancer, particularly through the use of RAF inhibitors.
Latest Patents
Ken Kobayashi holds a patent for the "Treatment of cancer with a RAF inhibitor." This patent outlines compositions and methods for treating cancer, which include a RAF inhibitor. Some embodiments of this invention feature combination therapy that incorporates the RAF inhibitor alongside at least one oncology therapeutic agent. He has 1 patent to his name.
Career Highlights
Ken Kobayashi is currently employed at Pierre Fabre Medicament, where he continues to advance his research in cancer treatment. His work is pivotal in developing new therapeutic strategies that can improve patient outcomes in oncology.
Collaborations
Ken collaborates with talented professionals in his field, including Aleksandra Franovic and Eric Martin. Their combined expertise contributes to the innovative projects at Pierre Fabre Medicament.
Conclusion
Ken Kobayashi's contributions to cancer treatment through his patented innovations highlight his role as a key figure in the field of oncology. His ongoing work promises to make a significant impact on cancer therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile